Carregant...

Commentary: Chronic Lymphocytic Leukemia—The Price of Progress

The study looks at the high cost of new treatments for chronic lymphocytic leukemia and calls for the consideration of a standardized and transparent method to determine the price of new drugs based on comparative effectiveness.

Guardat en:
Dades bibliogràfiques
Autors principals: Shanafelt, Tait D., Gunderson, Heidi, Call, Timothy G.
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227992/
https://ncbi.nlm.nih.gov/pubmed/20463087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0090
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!